Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/1995
09/20/1995EP0672180A1 Oligonucleotide modulation of protein kinase c
09/20/1995EP0672160A1 Activating expression of an amplifying endogenous gene by homologous recombination
09/20/1995EP0672159A1 In vivo homologous sequence targeting in eukaryotic cells
09/20/1995EP0672158A1 Virus with modified binding moiety specific for the target cells
09/20/1995EP0672153A1 Vector to deliver and express foreign gene
09/20/1995EP0672151A1 Inhibitors of ced-3 and related proteins
09/20/1995EP0672137A1 Gene therapy by retroviral vector with tumor suppressive gene
09/20/1995EP0672132A1 Receptor internalization signals
09/20/1995EP0672119A1 Retroviral mediated transfer of the human multiple drug resistance gene
09/20/1995EP0672064A1 Op-3-induced morphogenesis
09/20/1995EP0671954A1 Interferon gene therapy for the treatment of vascular disorders
09/20/1995EP0671928A1 Synthesis of n-substituted oligomers
09/20/1995EP0671923A1 Liver reserve cells
09/20/1995EP0652972A4 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure.
09/14/1995WO1995024489A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/14/1995WO1995024485A2 Coordinate in vivo gene expression
09/14/1995WO1995024473A1 Vascular endothelial growth factor 2
09/14/1995WO1995024469A1 Extracorporeal cell culture and transplantation kits
09/14/1995WO1995024466A1 Transforming growth factor alpha h1
09/14/1995WO1995024414A1 Fibroblast growth factor-10
09/14/1995WO1995024411A1 Corpuscles of stannius protein, stanniocalcin
09/14/1995WO1995024223A1 Inhibition of cell proliferation by e2f-1 antisense oligonucleotides
09/14/1995WO1995024221A1 Bioactive and/or targeted dendrimer conjugates
09/14/1995WO1995024205A1 Methods and compositions for treatment of breast cancer
09/14/1995WO1995024202A1 Ribozyme therapy for restenosis
09/14/1995WO1995024182A1 Human osteoclast-derived cathepsin
09/14/1995WO1995003406A3 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens
09/14/1995CA2443236A1 Human osteoclast-derived cathepsin
09/14/1995CA2414016A1 Vascular endothelial growth factor 2
09/14/1995CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/14/1995CA2184989A1 Ribozyme therapy for restenosis
09/14/1995CA2184905A1 Corpuscles of stannius protein, stanniocalcin
09/14/1995CA2184583A1 Transforming growth factor alpha h1
09/14/1995CA2184498A1 Extracorporeal cell culture and transplantation kits
09/14/1995CA2183961A1 Fibroblast growth factor-10
09/13/1995EP0670905A1 Recombinant viruses displaying a nonviral polypeptide on their external surface
09/13/1995EP0670904A1 Vector for the expression of therapy-relevant genes
09/13/1995EP0670899A1 Heat shock proteins and the treatment of tumours
09/13/1995EP0670897A1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE
09/13/1995EP0670737A1 In vivo peptide therapy
09/13/1995EP0661979A4 Cross-linking oligonucleotides for enzyme-mediated triple strand formation.
09/12/1995US5449755 Human cyclin E
09/12/1995US5449608 Detection
09/08/1995WO1995023867A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
09/08/1995WO1995023866A1 Vector for liver-specific gene therapy
09/08/1995WO1995023862A1 Animals with targeted gene disruption
09/08/1995WO1995023856A1 Chimeric complement inhibitor proteins
09/08/1995WO1995023855A2 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995WO1995023814A1 Product and process for t cell regulation
09/08/1995WO1995021927A3 Targeting gene therapy
09/08/1995WO1995019429A3 Method and reagent for inhibiting hepatitis c virus replication
09/08/1995CA2184810A1 Product and process for t cell regulation
09/08/1995CA2184580A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995CA2184355A1 Chimeric complement inhibitor proteins
09/08/1995CA2184113A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
09/06/1995EP0669987A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
09/06/1995EP0669977A1 Transformed endothelial cells
09/06/1995EP0669976A1 Transcription factor dp-1
09/06/1995EP0669973A1 Biological factors and neural stem cells
09/06/1995EP0669925A1 Aids therapeutics based on hiv ma peptides
09/06/1995CN1108030A New sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
08/1995
08/31/1995WO1995023234A1 Isolated, tyrosinase derived peptides and uses thereof
08/31/1995WO1995023225A2 Method and reagent for inhibiting the expression of disease related genes
08/31/1995WO1995023217A2 Treatment of diabetes mellitus and insulin receptor signal transduction
08/31/1995WO1995023216A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
08/31/1995WO1995023161A1 Growth arrest homeobox gene
08/31/1995DE4406073A1 Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten A process for the production of human, clonogenic fibroblasts method for Gentransfizierung of fibroblasts and fibroblasts thus obtained
08/31/1995CA2468048A1 Process for purifying chemically synthesized rna
08/31/1995CA2183992A1 Method and reagent for inhibiting the expression of disease related genes
08/31/1995CA2183863A1 Growth arrest homeobox gene
08/31/1995CA2183438A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
08/30/1995EP0668933A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
08/30/1995EP0668913A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
08/30/1995EP0668782A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer
08/30/1995EP0668781A1 Lymphokine gene therapy of cancer
08/30/1995EP0668777A1 Prostate-specific membrane antigen
08/30/1995EP0668771A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs
08/30/1995EP0469025B1 Improvements in or relating to enhancers
08/24/1995WO1995022618A1 Nucleic acid delivery system, method of synthesis and uses thereof
08/24/1995WO1995022617A1 Host-vector system for use in gene therapy
08/24/1995WO1995022611A2 Methods and compositions for stimulating bone cells
08/24/1995WO1995022608A1 Galanin receptor, nucleic acids, transformed cells and uses thereof
08/24/1995WO1995022604A1 Rna editing enzyme and methods of use thereof
08/24/1995WO1995022340A1 Methods for altering fertility
08/24/1995CA2183667A1 Nucleic acid delivery system, method of synthesis and uses thereof
08/24/1995CA2183253A1 Rna editing enzyme and methods of use thereof
08/23/1995EP0668357A1 Vector for integration site independent gene expression in mammalian host cells
08/23/1995EP0668350A1 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
08/23/1995EP0667912A1 Defective adenovirus vectors and use thereof in gene therapy
08/23/1995EP0667899A1 Mutated growth factor receptor as medicament and its use for treating cancer
08/23/1995EP0667792A1 Specific tolerance in transplantation
08/23/1995EP0667791A1 Isolation, growth, differentiation and genetic engineering of human muscle cells
08/23/1995EP0667778A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene
08/17/1995WO1995021931A1 Nucleic acid-containing composition, its preparation and use
08/17/1995WO1995021927A2 Targeting gene therapy
08/17/1995WO1995021630A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995WO1995021625A1 Prolactin as a vaccine adjuvant
08/17/1995WO1995021623A1 Peptides and methods against diabetes
08/17/1995WO1995021528A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
08/17/1995WO1995021527A1 Stem cell engraftment
1 ... 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 ... 870